Skip to main content
Have a personal or library account? Click to login
CD133/prominin1 is prognostic for GBM patient's survival, but inversely correlated with cysteine cathepsins' expression in glioblastoma derived spheroids Cover

CD133/prominin1 is prognostic for GBM patient's survival, but inversely correlated with cysteine cathepsins' expression in glioblastoma derived spheroids

Radiology and Oncology
Volume 45 (2011): Issue 2 (June 2011)
By: ,  ,  ,  ,  ,   and    
Open Access
|Jun 2011
References

References

  1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system.2007;: 97-109.
    Open DOISearch in Google Scholar
  2. Pilkington GJ. Cancer stem cells in the mammalian central nervous system.2005;: 423-33.
    Open DOISearch in Google Scholar
  3. Baur M, Preusser M, Piribauer M, Elandt K, Hassler M, Hudec M. Frequent MGMT (0(6)-methylguanine-DNA methyltransferase) hypermethylation in long-term survivors of glioblastoma: a single institution experience.2010;: 113-20.
    Open DOISearch in Google Scholar
  4. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells.2001;: 105-11.
    Open DOISearch in Google Scholar
  5. Bjerkvig R, Tysnes BB, Aboody KS, Najbauer J, Terzis AJ. Opinion: the origin of the cancer stem cell: current controversies and new insights.2005;: 899-904.
    Open DOISearch in Google Scholar
  6. Huse JT, Holland EC. Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma.2010;: 319-31.
    Open DOISearch in Google Scholar
  7. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.2006;: 756-9.
    Open DOISearch in Google Scholar
  8. Brabletz T, Jung A, Spaderna SW, Hlubek F, Kirchner T. Migrating cancer stem cells - an integrated concept of malignant tumour progression.2005;: 744-9.
    Open DOISearch in Google Scholar
  9. Cheng JX, Liu BL, Zhang X. How powerful is CD133 as a cancer stem cell marker in brain tumors?2009;: 403-8.
    Open DOISearch in Google Scholar
  10. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, et al. Identification of a cancer stem cell in human brain tumors.2003;: 5821-8.
    Search in Google Scholar
  11. Das S, Srikanth M, Kessler JA. Cancer stem cells and glioma.2008;: 427-35.
    Open DOISearch in Google Scholar
  12. Joo KM, Kim SY, Jin X, Song SY, Kong DS, Lee JI, et al. Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas.2008;: 808-15.
    Open DOISearch in Google Scholar
  13. Beier D, Hau P, Proeschold M, Lohmeier A, Wischhusen J, Oefner PJ, et al. CD133+ and CD133- glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.2007;: 4010-5.
    Open DOISearch in Google Scholar
  14. Wang J, Sakariassen PØ, Tsinkalovsky O, Immervoll H, Bøe SO, Svendsen A, et al. CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells.2008;: 761-8.
    Open DOISearch in Google Scholar
  15. Prestegarden L, Svendsen A, Wang J, Sleire L, Skaftnesmo KO, Bjerkvig R, et al. Glioma cell populations grouped by different cell type markers drive brain tumor growth.2010;: 4274-9.
    Open DOISearch in Google Scholar
  16. Koblinski JE, Ahram M, Sloane BF. Unraveling the role of proteases in cancer.2000;: 113-35.
    Open DOISearch in Google Scholar
  17. Lah TT, Durán Alonso MB, Van Noorden CJ. Antiprotease therapy in cancer: hot or not?2006;: 257-79.
    Open DOISearch in Google Scholar
  18. Gocheva V, Joyce JA. Cysteine cathepsins and the cutting edge of cancer invasion.2007;: 60-4.
    Open DOISearch in Google Scholar
  19. Levicar N, Nutall RK. Lah TT. Proteases in brain tumour progression.2003;: 825-38.
    Open DOISearch in Google Scholar
  20. Vranic A. Antigen expression on recurrent meningioma cells.2010;: 107-12.
    Open DOISearch in Google Scholar
  21. Lah T, Obermajer N, Duran-Alonso MB, Kos J. Cysteine cathepsins and cystatins as cancer biomarkers. In: Edwards DR, editor.. New York: Springer; 2008. p. 585-23.
    Search in Google Scholar
  23. Strojnik T, Kavalar R, Trinkaus M, Lah TT. Cathepsin L in glioma progression: comparison with cathepsin B.2005;: 448-55.
    Open DOISearch in Google Scholar
  24. Colin C, Voutsinos-Porche B, Nanni I, Fina F, Metellus PH, Intagliata D, et al. High expression of cathepsin B and plasminogen activator inhibitor type-1 are strong predictors of survival in glioblastomas.2009;: 745-54.
    Open DOISearch in Google Scholar
  25. Gole B, Durán Alonso MB, Dolenc V, Lah TT. Post-translational regulation of cathepsin B, but not other cysteine cathepsins, contributes to increase glioblastoma cell invasion in vitro.2009; 15: 711-23.
    Open DOISearch in Google Scholar
  26. Sivaparvathi M, Yamamoto M, Nicolson GL, Gokaslan ZL, Fuller GN, Liotta LA, et al. Expression and immunohistochemical localization of cathepsin L during the progression of human gliomas.1996; 14: 27-34.
    Open DOISearch in Google Scholar
  27. Lah TT, Strojnik T, Levicar N, Bervar A, Zajc I, Pilkington G, et al. Clinical and experimental studies of cysteine cathepsins and their inhibitors in human brain tumors.2000;: 90-3.
    Open DOISearch in Google Scholar
  28. Levičar N, Dewey RA, Daley E, Bates TE, Davies D, Kos J, et al. Selective suppression of cathepsin L by antisense cDNA impairs human brain tumor cell invasion in vitro and promotes apoptosis.2003;: 141-51.
    Open DOISearch in Google Scholar
  29. Zajc I, Hreljac I, Lah T. Cathepsin L affects apoptosis of glioblastoma cells: a potential implication in the design of cancer therapeutics.2006;: 3357-64.
    Search in Google Scholar
  30. Flannery T, McQuaid S, McGoohan C, McConnell RS, McGregor G, Mirakhur M, et al. Cathepsin S expression: An independent prognostic factor in glioblastoma tumours-A pilot study.2006;: 854-60.
    Open DOISearch in Google Scholar
  31. Kos J, Lah TT. Cystatins in cancer. In: Žerovnik E, Kopitar-Jerala N (eds).. New York: Nova Science Publishers Inc; 2006. p. 152-65.
    Search in Google Scholar
  32. Sakariassen PØ, Prestegarden L, Wang J, Skaftnesmo KO, Mahesparan R, Molthoff C, et al. Angiogenesis-independent tumor growth mediated by stem-like cancer cells.2006;: 16466-71.
    Open DOISearch in Google Scholar
  33. Palmer TD, Schwartz PH, Taupin P, Kaspar B, Stein SA, Gage FH. Progenitor cells from human brain after death.2001; 411: 42-3.
    Open DOISearch in Google Scholar
  34. Campos B, Wan F, Farhadi M, Ernst A, Zeppernick F, Tagscherer KE, et al. Differentiation therapy exerts antitumour effects on stem-like glioma cells.2010;: 2715-28.
    Open DOISearch in Google Scholar
  35. Demuth T, Rennert JL, Hoelzinger DB, Reavie LB, Nakada M, Beaudry C, et al. Glioma cells on the run - the migratory transcriptome of 10 human glioma cell lines.2008;: 54.
    Open DOISearch in Google Scholar
  36. Campos B, Herold-Mende CC. Insight into the complex regulation of CD133 in glioma.2010;: 501-10.
    Open DOISearch in Google Scholar
  37. Wu Y, Wu PY. CD133 as a marker for cancer stem cells: progresses and concerns.2009;: 1127-34.
    Open DOISearch in Google Scholar
  38. Zeppernick F, Ahmadi R, Campos B, Dictus C, Helmke BM, Becker N, et al. Stem cell marker CD133 affects clinical outcome in glioma patients.2008;: 123-9.
    Open DOISearch in Google Scholar
  39. Pallini R, Ricci-Vitiani L, Banna GL, Signore M, Lombardi D, Todaro M, et al. Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme.2008;: 8205-12.
    Open DOISearch in Google Scholar
  40. Kong D-S, Kim MH, Park W-Y, Suh Y-L, Lee J-I, Park K, et al. The progression of gliomas is associated with cancer stem cell phenotype.2008;: 639-43.
    Search in Google Scholar
  41. Strojnik T, Røsland GV, Sakariassen PO, Kavalar R, Lah Turnsek T. Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival.2007;: 133-43.
    Open DOISearch in Google Scholar
  42. Birgersdotter A, Sandberg R, Ernberg I. Gene expression perturbation in vitro-a growing case for three-dimensional (3D) culture systems.2005;: 405-12.
    Open DOISearch in Google Scholar
  43. Karcher S, Steiner HH, Ahmadi R, Zoubaa S, Vasvari G, Bauer H, et al. Different angiogenic phenotypes in primary and secondary glioblastomas.2006;: 2182-9.
    Open DOISearch in Google Scholar
  44. Yu SC, Ping YF, Yi L, Zhou ZH, Chen JH, Yao XH, et al. Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87.2008;: 124-34.
    Open DOISearch in Google Scholar
  45. Schmitt M, Jaenicke F, Graeff H. Protease, matrix degradation and tumourcell spread.1992;: 1-17.
    Search in Google Scholar
  46. Friedl P, Wolf K. Tumour cell invasion and migration. Diversity and escape mechanisms.2003; 3: 362-74.
    Open DOISearch in Google Scholar
  47. Zajc I, Bervar A, Lah Turnšek T. Cysteine cathepsins, stefins and extracellular matrix degradation during invasion of transformed human breast cell lines.2006;: 259-71.
    Search in Google Scholar
  48. Strojan P. Cysteine cathepsins and stefins in head and neck cancer: an update of clinical studies.2008;: 69-81.
    Open DOISearch in Google Scholar
  49. Berquin LM, Sloane BF. Cathepsin B expression in human tumours.1996;: 281-94.
    Open DOISearch in Google Scholar
  50. Urbich C, Heeschen C, Aicher A, Sasaki K, Bruhl T, Farhadi MR, at al. Cathepsin L is required for endothelial progenitor cell-induced neovascularization.2005;: 206-13.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/v10019-011-0015-6 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 102 - 115
Published on: Jun 3, 2011
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
CD133/prominin1,
cysteine cathepsins,
glioblastoma,
glioma stem cells,
invasion,
neural stem cells
Related subjects:
Medicine,
Clinical medicine,
Radiology

© 2011 Seyed Ardebili, Irena Zajc, Boris Gole, Benito Campos, Christel Herold-Mende, Sara Drmota, Tamara Lah, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.

Volume 45 (2011): Issue 2 (June 2011)
Previous article
Next article